I. A. Khalil, C. Troeger, B. F. Blacker, P. C. Rao, A. Brown et al., Morbidity and mortality due to shigella and enterotoxigenic Escherichia coli diarrhoea: the Global Burden of Disease Study 1990-2016, Lancet Infect Dis, issue.18, pp.30475-30479, 2018.

M. Mokomane, I. Kasvosve, E. De-melo, J. M. Pernica, and D. M. Goldfarb, The global problem of childhood diarrhoeal diseases: emerging strategies in prevention and management, Ther Adv Infect Dis, vol.5, issue.1, pp.29-43, 2017.

A. L. Bourgeois, T. F. Wierzba, and R. I. Walker, Status of vaccine research and development for enterotoxigenic Escherichia coli, Vaccine, vol.34, issue.26, pp.2880-2886, 2016.

S. Mani, T. Wierzba, and R. I. Walker, Status of vaccine research and development for Shigella, Vaccine, vol.34, issue.26, pp.2887-94, 2016.

M. A. Mcarthur, M. Maciel, and M. F. Pasetti, Human immune responses against Shigella and enterotoxigenic E. coli: current advances and the path forward, Vaccine, vol.35, pp.6803-6809, 2017.

J. Holmgren, U. D. Parashar, S. Plotkin, J. Louis, S. P. Ng et al., Correlates of protection for enteric vaccines, Vaccine, vol.35, issue.26, pp.3355-63, 2017.

F. Qadri, A. Saha, T. Ahmed, A. Tarique, A. Begum et al., Disease burden due to enterotoxigenic Escherichia coli in the first 2 years of life in an urban community in Bangladesh, Infect Immun, vol.75, issue.8, pp.3961-3969, 2007.

T. R. Bhuiyan, M. R. Hoq, N. S. Nishat, A. Mahbuba, D. Rashu et al., Enumeration of gut-homing b7-positive, pathogen-specific antibodysecreting cells in whole blood from enterotoxigenic Escherichia coli-and vibrio cholerae-infected patients, determined using an enzyme-linked immunosorbent spot assay technique, Clin Vacc Immunol, vol.23, issue.1, pp.27-36, 2015.

M. M. Alam, A. Aktar, S. Afrin, M. A. Rahman, S. Aktar et al., Antigen-specific memory B-cell responses to enterotoxigenic Escherichia coli infection in Bangladeshi adults, PLoS Negl Trop Dis, vol.8, issue.4, 2014.

A. M. Svennerholm and A. Lundgren, Recent progress toward an enterotoxigenic Escherichia coli vaccine, Expert Rev Vacc, vol.11, issue.4, pp.495-507, 2012.

M. Jertborn, C. Ahrén, and A. M. Svennerholm, Dose-dependent circulating immunoglobulin A antibody-secreting cell and serum antibody responses in Swedish volunteers to an oral inactivated enterotoxigenic Escherichia coli vaccine, Clin Diagn Lab Immunol, vol.8, issue.2, pp.424-432, 2001.

S. J. Savarino, E. R. Hall, S. Bassily, F. M. Brown, F. Youssef et al., Oral, inactivated, whole cell enterotoxigenic Escherichia coli plus cholera toxin B subunit vaccine: results of the initial evaluation in children. PRIDE Study Group, J Infect Dis, vol.179, issue.1, pp.107-121, 1999.

E. R. Hall, T. F. Wierzba, C. Ahrén, M. R. Rao, S. Bassily et al., Induction of systemic antifimbria and antitoxin antibody responses in Egyptian children and adults by an oral, killed enterotoxigenic Escherichia coli plus cholera toxin B subunit vaccine, Infect Immun, vol.69, issue.5, pp.2853-2860, 2001.

D. A. Sack, J. Shimko, O. Torres, A. L. Bourgeois, D. S. Francia et al., Randomised, double-blind, safety and efficacy of a killed oral vaccine for enterotoxigenic E. Coli diarrhoea of travellers to Guatemala and Mexico, Vaccine, vol.25, pp.4392-440, 2007.

M. R. Rao, T. F. Wierzba, S. J. Savarino, R. Abu-elyazeed, N. El-ghoreb et al., Serologic correlates of protection against enterotoxigenic Escherichia coli diarrhea, J Infect Dis, vol.191, issue.4, pp.562-70, 2005.

A. Lundgren, L. Bourgeois, N. Carlin, J. Clements, B. Gustafsson et al., Safety and immunogenicity of an improved oral inactivated multivalent enterotoxigenic Escherichia coli (ETEC) vaccine administered alone and together with dmLT adjuvant in a double-blind, randomized, placebocontrolled Phase I study, Vaccine, vol.32, issue.52, pp.7077-84, 2014.

A. Lundgren, M. Jertborn, and A. M. Svennerholm, Induction of long term mucosal immunological memory in humans by an oral inactivated multivalent enterotoxigenic Escherichia coli vaccine, Vaccine, vol.34, issue.27, pp.3132-3172, 2016.

M. Akhtar, M. I. Chowdhury, T. R. Bhuiyan, J. Kaim, T. Ahmed et al., Evaluation of the safety and immunogenicity of the oral inactivated multivalent enterotoxigenic Escherichia coli vaccine ETVAX in Bangladeshi adults in a double-blind, randomized, placebo-controlled Phase I trial using electrochemiluminescence and ELISA assays for immunogenicity analyses, Vaccine, issue.18, pp.31563-31572, 2018.

J. D. Dubreuil, R. E. Isaacson, and D. M. Schifferli, Animal enterotoxigenic Escherichia coli. EcoSal Plus, vol.7, 2016.

F. Meurens, A. Summerfield, H. Nauwynck, L. Saif, and V. Gerdts, The pig: a model for human infectious diseases, Trends Microbiol, vol.20, issue.1, pp.50-57, 2011.
URL : https://hal.archives-ouvertes.fr/hal-02652897

V. Melkebeek, K. Rasschaert, P. Bellot, K. Tilleman, H. Favoreel et al., Targeting aminopeptidase N, a newly identified receptor for F4ac fimbriae, enhances the intestinal mucosal immune response, Mucosal Immunol, vol.5, issue.6, pp.635-680, 2012.

A. Coddens, M. Diswall, J. Angström, M. E. Breimer, B. Goddeeris et al., Recognition of blood group ABH type 1 determinants by the FedF adhesin of F18-fimbriated Escherichia coli, J Biol Chem, vol.284, issue.15, pp.9713-9739, 2009.

B. Devriendt, E. Stuyven, F. Verdonck, B. Goddeeris, and E. Cox, Enterotoxigenic Escherichia coli (K88) induce proinflammatory responses in porcine intestinal epithelial cells, Dev Comp Immunol, vol.34, issue.11, pp.1175-82, 2010.

Y. Luo, U. Van-nguyen, F. Rodriguez, P. Y. Devriendt, B. Cox et al., F4+ ETEC infection and oral immunization with F4 fimbriae elicits an IL-17-dominated immune response, Vet Res, vol.21, issue.46, p.121, 2015.
URL : https://hal.archives-ouvertes.fr/hal-01341430

W. Van-den-broeck, E. Cox, and B. M. Goddeeris, Receptor-dependent immune responses in pigs after oral immunization with F4 fimbriae, Infect Immun, vol.67, issue.2, pp.520-526, 1999.

F. Verdonck, E. Cox, K. Van-gog, Y. Van-der-stede, L. Duchateau et al., Different kinetic of antibody responses following infection of newly weaned pigs with an F4 enterotoxigenic Escherichia coli strain or an F18 verotoxigenic Escherichia coli strain, Vaccine, vol.20, pp.2995-3004, 2002.

U. V. Nguyen, V. Melkebeek, B. Devriendt, T. Goetstouwers, M. Van-poucke et al., Maternal immunity enhances systemic recall immune responses upon oral immunization of piglets with F4 fimbriae, Vet Res, vol.23, issue.46, p.72, 2015.
URL : https://hal.archives-ouvertes.fr/hal-01336310

V. Virdi, A. Coddens, D. Buck, S. Millet, S. Goddeeris et al., Orally fed seeds producing designer IgAs protect weaned piglets against enterotoxigenic Escherichia coli infection, Proc Natl Acad Sci, vol.110, issue.29, pp.11809-11823, 2013.

J. Zhu, H. Yamane, and W. E. Paul, Differentiation of effector CD4 T cell populations (*), Annu Rev Immunol, vol.28, pp.445-89, 2010.

R. Morita, N. Schmitt, S. E. Bentebibel, R. Ranganathan, L. Bourdery et al., Human blood CXCR5(+)CD4(+) T cells are counterparts of T follicular cells and contain specific subsets that differentially support antibody secretion, Immunity, vol.34, issue.1, pp.108-129, 2011.

M. A. Mcarthur, W. H. Chen, L. Magder, M. M. Levine, and M. B. Sztein, Impact of CD4+ T cell responses on clinical outcome following oral administration of wild-type enterotoxigenic Escherichia coli in humans, PLoS Negl Trop Dis, vol.11, issue.1, p.5291, 2017.

J. R. Mora, M. Iwata, B. Eksteen, S. Y. Song, T. Junt et al., Generation of gut-homing IgA-secreting B cells by intestinal dendritic cells, Science, vol.314, issue.5802, pp.1157-60, 2006.

A. Cardeno, M. K. Magnusson, M. Quiding-jarbrink, and A. Lundgren, Activated T follicular helper-like cells are released into blood after oral vaccination and correlate with vaccine specific mucosal B-cell memory, Sci Rep, vol.8, issue.1, p.2729, 2018.

H. L. Dupont, R. B. Hornick, M. J. Snyder, J. P. Libonati, S. B. Formal et al., Immunity in shigellosis. II. Protection induced by oral live vaccine or primary infection, J Infect Dis, vol.125, issue.1, pp.12-18, 1972.

S. B. Formal, E. V. Oaks, R. E. Olsen, M. Wingfield-eggleston, P. J. Snoy et al., Effect of prior infection with virulent Shigella flexneri 2a on the resistance of monkeys to subsequent infection with Shigella sonnei, J Infect Dis, vol.164, pp.533-540, 1991.

C. Ferreccio, V. Prado, and A. Ojeda, Epidemiologic patterns of acute diarrhea and endemic Shigella infections in children in a poor periurban setting in Santiago, Chile Am J Epidemiol, vol.134, issue.6, pp.614-641, 1991.

D. Cohen, R. Bassal, S. Goren, T. Rouach, D. Taran et al., Recent trends in the epidemiology of shigellosis in Israel, Epidemiol Infect, vol.142, issue.12, pp.2583-94, 2014.

Y. Lerman, M. Yavzori, R. Ambar, I. Sechter, M. Wiener et al., Epidemic spread of Shigella sonnei shigellosis and evidence for development of immunity among children attending day-care centers in a communal settlement (Kibbutz), J Clin Microbiol, vol.32, issue.4, pp.1092-1096, 1994.

D. Cohen, M. S. Green, C. Block, R. Slepon, and I. Ofek, Prospective study of the association between serum antibodies to lipopolysaccharide O antigen and the attack rate of shigellosis, J Clin Microbiol, vol.29, issue.2, pp.386-395, 1991.

D. Cohen, M. S. Green, C. Block, T. Rouach, and I. Ofek, Serum antibodies to lipopolysaccharide and natural immunity to shigellosis in an Israeli military population, J Infect Dis, vol.157, issue.5, pp.1068-71, 1988.

R. E. Black, M. M. Levine, M. L. Clements, G. Losonsky, D. Herrington et al., Prevention of shigellosis by a Salmonella typhi-Shigella sonnei bivalent vaccine, J Infect Dis, vol.155, issue.6, pp.1260-1265, 1987.

J. B. Robbins, C. Chu, and R. Schneerson, Hypothesis for vaccine development: protective immunity to enteric diseases caused by nontyphoidal salmonellae and shigellae may be conferred by serum IgG antibodies to the O-specific polysaccharide of their lipopolysaccharides, Clin Infect Dis, vol.15, issue.2, pp.346-61, 1992.

J. B. Robbins and R. Schneerson, Polysaccharide-protein conjugates: a new generation of vaccines, J Infect Dis, vol.161, issue.5, pp.821-853, 1990.

D. Cohen, S. Ashkenazi, M. S. Green, M. Gdalevich, G. Robin et al., Doubleblind vaccine-controlled randomised efficacy trial of an investigational Shigella sonnei conjugate vaccine in young adults, Lancet, vol.349, issue.9046, pp.155-164, 1997.

D. Cohen, S. Ashkenazi, M. Green, Y. Lerman, R. Slepon et al., Safety and immunogenicity of investigational Shigella conjugate vaccines in Israeli volunteers, Infect Immun, vol.64, issue.10, pp.4074-4081, 1996.

J. H. Passwell, S. Ashkenzi, Y. Banet-levi, R. Ramon-saraf, N. Farzam et al., Age-related efficacy of Shigella O-specific polysaccharide conjugates in 1-4-year-old Israeli children, Vaccine, vol.28, issue.10, pp.2231-2236, 2010.

A. Phalipon, M. Tanguy, C. Grandjean, C. Guerreiro, F. Bélot et al., A synthetic carbohydrate-protein conjugate vaccine candidate against Shigella flexneri 2a infection, J Immunol, vol.182, issue.4, pp.2241-2248, 2009.
URL : https://hal.archives-ouvertes.fr/hal-00414256

R. Van-der-put, T. H. Kim, C. Guerreiro, F. Thouron, P. Hoogerhout et al., A synthetic carbohydrate conjugate vaccine candidate against shigellosis: improved bioconjugation and impact of alum on immunogenicity, Bioconj Chem, vol.27, issue.4, pp.883-92, 2016.
URL : https://hal.archives-ouvertes.fr/pasteur-01350027

V. Pozsgay, C. Chu, L. Pannell, J. Wolfe, J. B. Robbins et al., Protein conjugates of synthetic saccharides elicit higher levels of serum IgG lipopolysaccharide antibodies in mice than do those of the O-specific polysaccharide from Shigella dysenteriae type 1, Proc Natl Acad Sci, vol.96, pp.5194-5201, 1999.

K. Nothelfer, E. T. Arena, L. Pinaud, M. Neunlist, B. Mozeleski et al., B lymphocytes undergo TLR2-dependent apoptosis upon Shigella infection, J Exp Med, vol.211, issue.6, pp.1215-1244, 2014.

K. Nothelfer, P. J. Sansonetti, and A. Phalipon, Pathogen manipulation of B cells: the best defence is a good offence, Nat Rev Microbiol, vol.13, issue.3, pp.173-84, 2015.

G. Sellge, J. G. Magalhaes, C. Konradt, J. H. Fritz, W. Salgado-pabon et al., Th17 cells are the dominant T cell subtype primed by Shigella flexneri mediating protective immunity, J Immunol, vol.184, issue.4, pp.2076-85, 2010.

H. Ashida, M. Ogawa, M. Kim, S. Suzuki, T. Sanada et al., Shigella deploy multiple countermeasures against host innate immune responses, Curr Opin Microbiol, vol.14, issue.1, pp.16-23, 2011.

H. Ashida, M. Ogawa, H. Mimuro, T. Kobayashi, T. Sanada et al., Shigella are versatile mucosal pathogens that circumvent the host innate immune system, Curr Opin Immunol, vol.23, issue.4, pp.448-55, 2011.

S. S. Way, A. C. Borczuk, R. Dominitz, and M. B. Goldberg, An essential role for gamma interferon in innate resistance to Shigella flexneri infection, Infect Immun, vol.66, issue.4, pp.1342-1350, 1998.

R. Raqib, A. A. Lindberg, B. Wretlind, P. K. Bardhan, U. Andersson et al., Persistence of local cytokine production in shigellosis in acute and convalescent stages, Infect Immun, vol.63, issue.1, pp.289-96, 1995.

R. Raqib, A. Ljungdahl, A. A. Lindberg, U. Andersson, and J. Andersson, Local entrapment of interferon [gamma] in the recovery from Shigella dysenteriae type 1 infection, Gut, vol.38, pp.328-364, 1996.

A. Karnell, Safety and immunogenicity study of the auxotrophic Shigella flexneri 2a vaccine SFL1070 with a deleted aroD gene in adult Swedish volunteers, Vaccine, vol.13, pp.88-97, 1995.

K. L. Kotloff, Safety, immunogenicity, and transmissibility in humans of CVD 1203, a live oral Shigella flexneri 2a vaccine candidate attenuated by deletions in aroA and virG, Infect Immun, vol.64, pp.4542-4550, 1996.

T. Samandari, K. L. Kotloff, G. A. Losonsky, W. D. Picking, P. J. Sansonetti et al., Production of IFN-c and IL-10 to Shigella invasins by mononuclear cells from volunteers orally inoculated with a shiga toxin-deleted Shigella dysenteriae type 1 strain, J Immunol, vol.164, issue.4, pp.2221-2253, 2000.

K. Kotloff, Phase 1 evaluation of a vriG deleted Shigella sonnei live, attenuated vaccine (strain WRSS1) in healthy adult volunteers, Infect Immun, vol.70, pp.2016-2037, 2002.

K. L. Kotloff, J. K. Simon, M. F. Pasetti, M. B. Sztein, S. L. Wooden et al., Safety and immunogenicity of CVD 1208S, a live, oral DeltaguaBA Deltasen Deltaset Shigella flexneri 2a vaccine grown on animal-free media, Hum Vaccin, vol.3, issue.6, pp.268-75, 2007.

F. R. Toapanta, P. J. Bernal, K. L. Kotloff, M. M. Levine, and M. B. Sztein, T cell mediated immunity induced by the live-attenuated Shigella flexneri 2a vaccine candidate CVD 1208S in humans, J Transl Med, vol.16, issue.1, p.61, 2018.

P. A. Darrah, D. T. Patel, D. Luca, P. M. Lindsay, R. W. Davey et al., Multifunctional TH1 cells define a correlate of vaccine-mediated protection against Leishmania major, Nat Med, vol.13, issue.7, pp.843-50, 2007.

R. A. Seder, P. A. Darrah, and M. Roederer, T-cell quality in memory and protection: implications for vaccine design, Nat Rev Immunol, vol.8, issue.4, pp.247-58, 2008.

R. Wahid, J. K. Simon, W. L. Picking, K. L. Kotloff, M. M. Levine et al., Shigella antigen-specific B memory cells are associated with decreased disease severity in subjects challenged with wild-type Shigella flexneri 2a, Clin Immunol, vol.148, issue.1, pp.35-43, 2013.

J. K. Simon, M. Maciel, E. D. Weld, R. Wahid, M. F. Pasetti et al., Antigen-specific IgA B memory cell responses to Shigella antigens elicited in volunteers immunized with live attenuated Shigella flexneri 2a oral vaccine candidates, Clin Immunol, vol.139, pp.185-92, 2011.

J. K. Simon, R. Wahid, M. Maciel, W. L. Picking, K. L. Kotloff et al., Antigen-specific B memory cell responses to lipopolysaccharide (LPS) and invasion plasmid antigen (Ipa) B elicited in volunteers vaccinated with live-attenuated Shigella flexneri 2a vaccine candidates, Vaccine, vol.27, issue.4, pp.565-572, 2009.

S. A. Plotkin, Correlates of protection induced by vaccination, Clin Vacc Immunol, vol.17, pp.1055-65, 2010.

S. A. Plotkin and P. B. Gilbert, Nomenclature for immune correlates of protection after vaccination, Clin Infect Dis Off Publ Infect Dis Soc Am, vol.54, issue.11, pp.1615-1622, 2012.

T. C. Darton, C. Jones, C. J. Blohmke, C. S. Waddington, L. Zhou et al., A randomised, double blind, placebo-controlled challenge study to assess the protective efficacy of the single-dose oral typhoid vaccine, M01ZH09, PLoS Negl Trop Dis, vol.10, issue.8, p.4926, 2016.

S. Fresnay, M. A. Mcarthur, L. Magder, T. C. Darton, C. Jones et al., Salmonella Typhi-specific multifunctional CD8+ T cells play a dominant role in protection from typhoid fever in humans, J Transl Med, vol.1, issue.14, p.62, 2016.